LIVE MARKETS-European healthcare and consumer stocks as AI hedges

By Reuters News

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com.

EUROPEAN HEALTHCARE AND CONSUMER STOCKS AS AI HEDGES

European fund managers often like to tout the region as offering diversification to AI trades, and while there's a lot of talking their book, the recent tech jitters suggest that certain pockets of the market do actually seem to work as hoped.

HSBC analysts say European consumer staples and healthcare stand out as the best AI hedges.

They say the Nasdaq has fallen by 1% on 22 occasions since June and on 86% of those, European consumer staples have risen. .SXCSP

Healthcare stocks haven't worked quite as well, but have risen nearly 70% of the time the Nasdaq has fallen 1%. .SXDP

HSBC are not getting too excited.

They say: "We do not expect the AI trade to roll over further. And in the face of a much deeper decline in global tech, these resilient sectors in Europe might come under pressure. Yet this highlights potential pockets to consider should such a scenario unfold."

Thursday is proving another test, which they are passing, for now. Nasdaq 100 futures are down 1.6% and European healthcare and consumer staples are up 0.8% and 0.3%, respectively.

(Alun John)

EARLIER LIVE MARKETS POSTS

GO LONG GILTS INTO THE BUDGET, UBS SAY CLICK HERE

LOTS OF REASONS TO SELL EUROPEAN STOCKS ON THURSDAY CLICK HERE

BEFORE THE BELL: LOTS OF COMPANIES REPORTING INTO A SHAKY MARKET CLICK HERE

MORNING BID FRANCE'S DEBT STRAINS, AI IN FOCUS CLICK HERE

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.